BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Varex to Present at the 2023 Jefferies Healthcare Conference

  Varex Imaging Corporation announced that management is scheduled to present at the Jefferies Healthcare Conference.

  June 5, 2023

   · 

  1 min read
• Policy

  PolyPid Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement and Transfer of its Listing to the Nasdaq Capital Market

  PolyPid Ltd. announced it has received an extension of the period to regain compliance with The Nasdaq Stock Market LLC’s minimum bid price rule and approval from Nasdaq to transfer the listing of the ordinary shares of the Company from The Nasdaq Global Market to The Nasdaq Capital Market.

  June 5, 2023

   · 

  5 min read
• Drug Development

  Erasca Provides Update on Clinical Program for ERK Inhibitor ERAS-007 and Refines Pipeline

  Erasca, Inc. (Nasdaq: ERAS) today announced promising preliminary Phase 1b data for ERK inhibitor ERAS-007 in patients with metastatic BRAF V600E-mutated (BRAFm) colorectal cancer (CRC) and provided a portfolio update.

  June 5, 2023

   · 

  10 min read
• Business

  Intellia Therapeutics Announces Retirement of Jean-François Formela, M.D. From its Board of Directors

  Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, today announced that Jean-François Formela, M.D. is retiring from its board of directors, effective June 15, 2023.

  June 5, 2023

   · 

  3 min read